COVID-19 infodemic and health-related quality of life in patients with chronic respiratory diseases: A multicentre, observational study.


Journal

Journal of global health
ISSN: 2047-2986
Titre abrégé: J Glob Health
Pays: Scotland
ID NLM: 101578780

Informations de publication

Date de publication:
10 Nov 2023
Historique:
medline: 13 11 2023
pubmed: 10 11 2023
entrez: 10 11 2023
Statut: epublish

Résumé

The explosion of information, misinformation and disinformation (the "infodemic") related to the coronavirus disease 2019 (COVID-19) pandemic on digital and social media is reported to affect mental health and quality of life. However, reports assessing the COVID-19 infodemic on health-related quality of life (HRQL) in patients with chronic diseases are scarce. In this study, we investigated the associations between the infodemic and HRQL in uninfected individuals with pre-existing chronic respiratory diseases (CRDs) such as asthma, chronic obstructive pulmonary disease (COPD) and other CRDs. We conducted a multi-national, cross-sectional, observational study in Canada, India, New Zealand and the United Kingdom where we distributed a set of digitised questionnaires among 1018 participants with chronic respiratory diseases who were not infected with the SARS-CoV-2 virus at least three months prior to the study. We collected information about the infodemic such as news watching or social media use more than usual during the pandemic. HRQL was assessed using the short form of the chronic respiratory questionnaire (SF-CRQ). Demographic information, comorbidities, compliance, mental health, behavioural function, and social support were also recorded. We analysed the direct and indirect relationships between infodemic and HRQL using structural equation models (SEM). Of all participants, 54% were females and had a mean (standard deviation (SD)) age of 53 (17) years. We found that higher infodemic was associated with worse emotional function (regression coefficient β = -0.08; 95% confidence interval (CI) = -0.14 to -0.01), which means a one SD change of the higher infodemic latent variable was associated with a 0.08 SD change of emotional function level. The association between higher infodemic and worse emotional function was mediated by worse mental health and behavioural functions but is marginally ameliorated by improved social support. In stratification analysis, we found significant disease and country-wise variations in the associations between infodemic and SF-CRQ domain scores. These results provide new evidence that the COVID-19 infodemic significantly influences the HRQL in patients with CRDs through a complex interplay between mental health, behavioural function, and social support. This new dimension of research also opens avenues for further research on infodemic-related health effects in other chronic diseases.

Sections du résumé

Background UNASSIGNED
The explosion of information, misinformation and disinformation (the "infodemic") related to the coronavirus disease 2019 (COVID-19) pandemic on digital and social media is reported to affect mental health and quality of life. However, reports assessing the COVID-19 infodemic on health-related quality of life (HRQL) in patients with chronic diseases are scarce. In this study, we investigated the associations between the infodemic and HRQL in uninfected individuals with pre-existing chronic respiratory diseases (CRDs) such as asthma, chronic obstructive pulmonary disease (COPD) and other CRDs.
Methods UNASSIGNED
We conducted a multi-national, cross-sectional, observational study in Canada, India, New Zealand and the United Kingdom where we distributed a set of digitised questionnaires among 1018 participants with chronic respiratory diseases who were not infected with the SARS-CoV-2 virus at least three months prior to the study. We collected information about the infodemic such as news watching or social media use more than usual during the pandemic. HRQL was assessed using the short form of the chronic respiratory questionnaire (SF-CRQ). Demographic information, comorbidities, compliance, mental health, behavioural function, and social support were also recorded. We analysed the direct and indirect relationships between infodemic and HRQL using structural equation models (SEM).
Results UNASSIGNED
Of all participants, 54% were females and had a mean (standard deviation (SD)) age of 53 (17) years. We found that higher infodemic was associated with worse emotional function (regression coefficient β = -0.08; 95% confidence interval (CI) = -0.14 to -0.01), which means a one SD change of the higher infodemic latent variable was associated with a 0.08 SD change of emotional function level. The association between higher infodemic and worse emotional function was mediated by worse mental health and behavioural functions but is marginally ameliorated by improved social support. In stratification analysis, we found significant disease and country-wise variations in the associations between infodemic and SF-CRQ domain scores.
Conclusions UNASSIGNED
These results provide new evidence that the COVID-19 infodemic significantly influences the HRQL in patients with CRDs through a complex interplay between mental health, behavioural function, and social support. This new dimension of research also opens avenues for further research on infodemic-related health effects in other chronic diseases.

Identifiants

pubmed: 37947025
doi: 10.7189/jogh.13.06045
pmc: PMC10636600
doi:

Types de publication

Observational Study Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

06045

Informations de copyright

Copyright © 2023 by the Journal of Global Health. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure of interest: SM (Subhabrata Moitra) reports personal fees from Elsevier Inc. (USA), Synergy Respiratory & Cardiac Care (Canada), Permanyer Inc. (Spain); lecture fees from Apollo Gleneagles Hospital (India), and Institute of Allergy – Kolkata (India), outside the submitted work. FK reports grants from the Wellness of Workers (WoW) Program, Local 110 Heat & Frost Insulators & Allied Workers outside the present work. LM reports a grant from the Wellness of Workers (WoW) Program, Local 110 Heat & Frost Insulators & Allied Workers, outside the present work. NM reports non-financial support from GSK, non-financial support from AstraZeneca, non-financial support from Chiesi Farmaceutici, and non-financial support from Menarini, outside the submitted work. AS reports grants from the Health Research Council of New Zealand, outside the submitted work. AMT reports non-financial support from ResMed, during the conduct of the study; grants from National Institute of Health Research (United Kingdom); grants, personal fees, and non-financial support from AstraZeneca; grants and non-financial support from Chiesi; grants from Health Foundation, Alpha 1 Foundation, and ATS Foundation; personal fees and non-financial support from Boehringer Ingelheim, outside the submitted work. PL reports grants from the Wellness of Workers (WoW) Program, Local 110 Heat & Frost Insulators & Allied Workers, Synergy Respiratory Care Limited, AstraZeneca Canada, and the Natural Sciences and Engineering Research Council (NSERC) in Canada during the conduct of the study; and personal fees from AstraZeneca Canada and GSK Canada, outside the submitted work. Other authors do not have any conflict of interest to declare.

Références

JMIR Public Health Surveill. 2020 May 22;6(2):e19447
pubmed: 32412418
Trials. 2023 Jan 17;24(1):34
pubmed: 36650587
Soc Sci Humanit Open. 2021;4(1):100150
pubmed: 33880443
Curr Opin Psychiatry. 2021 Jul 1;34(4):376-385
pubmed: 34016817
Curr Med Res Opin. 2022 Jan;38(1):35-42
pubmed: 34551667
Eur J Neurol. 2020 Sep;27(9):1744-1747
pubmed: 32449791
PLoS One. 2022 May 19;17(5):e0267022
pubmed: 35587480
Lancet Respir Med. 2020 Jun;8(6):585-596
pubmed: 32526187
Ann Intern Med. 2020 Aug 18;173(4):317-320
pubmed: 32251513
J Med Internet Res. 2020 Apr 05;:
pubmed: 32250961
Chiropr Man Therap. 2020 Nov 18;28(1):65
pubmed: 33208144
JMIR Public Health Surveill. 2020 May 5;6(2):e19374
pubmed: 32338613
Monaldi Arch Chest Dis. 2020 Jun 03;90(2):
pubmed: 32498502
PLoS One. 2021 Mar 15;16(3):e0248591
pubmed: 33720985
BMJ. 2020 May 4;369:m1702
pubmed: 32366504
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):1445-1447
pubmed: 32755849
Am J Prev Med. 2017 Jan;52(1S1):S5-S12
pubmed: 27989293
Cancers (Basel). 2020 Aug 14;12(8):
pubmed: 32823999
BMC Public Health. 2021 Jun 23;21(1):1200
pubmed: 34162357
Ann Intern Med. 2007 Oct 16;147(8):573-7
pubmed: 17938396
J Infect Public Health. 2021 Aug;14(8):1087-1088
pubmed: 34245973
Intern Med J. 2021 Mar;51(3):414-418
pubmed: 33738951
Lancet Gastroenterol Hepatol. 2020 Oct;5(10):886-887
pubmed: 32763197
Rev Med Virol. 2022 Jul;32(4):e2313
pubmed: 34755408
Headache. 2022 Mar;62(3):284-293
pubmed: 35294046
Front Psychol. 2022 May 19;13:718313
pubmed: 35664184
Otolaryngol Head Neck Surg. 2007 Jan;136(1):14-8
pubmed: 17210326
Health Expect. 2021 Jun;24(3):978-990
pubmed: 33769657
Medicine (Baltimore). 2022 May 06;101(18):e29145
pubmed: 35550463
Psychiatry Res. 2020 Jun;288:112936
pubmed: 32276196
Lancet. 2020 Nov 7;396(10261):1474
pubmed: 33160553
Int J Chron Obstruct Pulmon Dis. 2014 Nov 13;9:1289-306
pubmed: 25419126
J Allergy Clin Immunol Pract. 2023 Jul;11(7):2115-2124.e7
pubmed: 37087095
Clin Rheumatol. 2022 Oct;41(10):3211-3218
pubmed: 35790594
Harv Kennedy Sch Misinformation Rev. 2020 Sep;1:
pubmed: 34368805
J Clin Epidemiol. 2008 May;61(5):489-97
pubmed: 18394543
COPD. 2021 Oct;18(5):549-556
pubmed: 34486469
Behav Res Methods. 2019 Feb;51(1):409-428
pubmed: 29869222
Indian J Nephrol. 2020 May-Jun;30(3):188-191
pubmed: 33013069
Health Qual Life Outcomes. 2014 Apr 25;12:58
pubmed: 24761773
J Med Internet Res. 2020 Nov 16;22(11):e22639
pubmed: 33156807
BMC Public Health. 2022 Apr 23;22(1):816
pubmed: 35461254
Cureus. 2020 Mar 13;12(3):e7255
pubmed: 32292669
Value Health. 2015 Mar;18(2):292-8
pubmed: 25773565
J Med Internet Res. 2020 May 19;22(5):e19556
pubmed: 32369026
Schizophr Res. 2000 May 5;42(3):241-7
pubmed: 10785582
Chron Respir Dis. 2020 Jan-Dec;17:1479973120962800
pubmed: 33000648
Hum Vaccin Immunother. 2021 Sep 2;17(9):2962-2964
pubmed: 33890838
J Hosp Med. 2021 Nov;16(11):659-666
pubmed: 34730508
Soc Netw Anal Min. 2021;11(1):45
pubmed: 33972828
J Allergy Clin Immunol. 1999 Jan;103(1 Pt 1):72-8
pubmed: 9893188
Sci Data. 2022 May 31;9(1):250
pubmed: 35641518
J Med Internet Res. 2020 Oct 12;22(10):e21597
pubmed: 32960775
J Psychiatr Ment Health Nurs. 2021 Apr;28(2):300
pubmed: 32352621
Med Care. 1998 Jan;36(1):8-27
pubmed: 9431328
Brain Behav Immun. 2020 Aug;88:559-565
pubmed: 32330593
J Nurs Scholarsh. 2005;37(4):336-42
pubmed: 16396406
Brain Behav Immun. 2020 Jul;87:75-79
pubmed: 32325098
Front Psychiatry. 2020 Apr 14;11:306
pubmed: 32346373
Joint Bone Spine. 2021 Oct;88(5):105212
pubmed: 33992793
Intensive Care Med. 2020 Nov;46(11):2026-2034
pubmed: 32886208
Eur J Investig Health Psychol Educ. 2022 Oct 20;12(10):1559-1571
pubmed: 36286093

Auteurs

Subhabrata Moitra (S)

Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

Augustus Anderson (A)

Medical Research Institute of New Zealand, Wellington, New Zealand.

Allie Eathorne (A)

Medical Research Institute of New Zealand, Wellington, New Zealand.

Amanda Brickstock (A)

Department of Respiratory Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, England, UK.

Ana Adan (A)

Department of Clinical Psychology and Psychobiology, University of Barcelona, Barcelona, Spain.
Institute of Neurosciences, University of Barcelona, Barcelona, Spain.

Metin Akgün (M)

Department of Chest Diseases, Ataturk University, Erzurum, Turkey.

Ali Farshchi Tabrizi (AF)

Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

Prasun Haldar (P)

Department of Medical Laboratory Technology, Supreme Institute of Management and Technology, Mankundu, India.
Department of Physiology, West Bengal State University, Barasat, India.

Linda Henderson (L)

Synergy Respiratory and Cardiac Care, Sherwood Park, Alberta, Canada.

Aditya Jindal (A)

Jindal Clinics, Chandigarh, India.

Surinder Kumar Jindal (SK)

Jindal Clinics, Chandigarh, India.

Bugra Kerget (B)

Department of Chest Diseases, Ataturk University, Erzurum, Turkey.

Fadi Khadour (F)

Synergy Respiratory and Cardiac Care, Sherwood Park, Alberta, Canada.

Lyle Melenka (L)

Synergy Respiratory and Cardiac Care, Sherwood Park, Alberta, Canada.

Saibal Moitra (S)

Department of Allergy & Immunology, Apollo Multispeciality Hospital, Kolkata, India.

Tanusree Moitra (T)

Department of Psychology, Barrackpore Rashtraguru Surendrananth College, Barrackpore, India.

Rahul Mukherjee (R)

Department of Respiratory Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, England, UK.
Institute of Applied Health Research, University of Birmingham, Birmingham, England, United Kingdom.

Nicola Murgia (N)

Department of Environmental and Prevention Sciences, University of Ferrara, Ferrara, Italy.

Alex Semprini (A)

Medical Research Institute of New Zealand, Wellington, New Zealand.

Alice M Turner (AM)

Department of Respiratory Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, England, UK.
Institute of Applied Health Research, University of Birmingham, Birmingham, England, United Kingdom.

Paige Lacy (P)

Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH